https://ria.ru/20200814/1575768553.html
Murashko announced the publication of research on a vaccine against coronavirus
Data on preclinical and clinical studies of a new vaccine against coronavirus will be published in the near future, said the head of the Ministry of Health Mikhail Murashko. RIA Novosti, 08/14/2020
2020-08-14T08:05
2020-08-14T08:45
the spread of the new coronavirus
михаил мурашко
/html/head/meta[@name=”og:title”]/@content
/html/head/meta[@name=”og:description”]/@content
–
https://cdn23.img.ria.ru/images/07e4/08/0c/1575682304_0:123:3072:1851_1400x0_80_0_0_9a95411f90899018a952711824312963.jpg
6
RIA Novosti
Russia, Moscow, Zubovsky Boulevard, 4
7 495 645-6601
https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/
–
2020
RIA Novosti
Russia, Moscow, Zubovsky Boulevard, 4
7 495 645-6601
https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/
ru-RU
https://ria.ru/docs/about/copyright.html
https://xn--c1acbl2abdlkab1og.xn--p1ai/
RIA Novosti
Russia, Moscow, Zubovsky Boulevard, 4
7 495 645-6601
https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/
–
https://cdn23.img.ria.ru/images/07e4/08/0c/1575682304_0:123:3072:1851_1400x0_80_0_0_9a95411f90899018a952711824312963.jpg
https://cdn22.img.ria.ru/images/07e4/08/0c/1575682304_341:0:3072:2048_1400x0_80_0_0_63223dde50ed2d8e3ad354162d4b7101.jpg
https://cdn25.img.ria.ru/images/07e4/08/0c/1575682304_336:0:2384:2048_1400x0_80_0_0_349843a649e9165c7459a701f6e84db0.jpg
RIA Novosti
Russia, Moscow, Zubovsky Boulevard, 4
7 495 645-6601
https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/
–
RIA Novosti
Russia, Moscow, Zubovsky Boulevard, 4
7 495 645-6601
https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/
–
coronavirus in russia, coronavirus covid-19, mikhail murashko
–
“In the coming days, possibly by Monday,” the minister said.
—
He noted that criticism of the new Russian vaccine is largely due to the fact “that more data needs to be obtained from research”, adding that not everyone knows that “the vaccine is released on a platform on which six products have already been made.”
–
Murashko also assured that clinical studies will continue.
–
According to information from the State Register of Medicines, the drug will be a solution for intramuscular injection. Vaccination is planned to be carried out in two stages: first – with component I, after three weeks – with component II.
–
According to the Ministry of Health, a two-time injection scheme allows the formation of long-term immunity for up to two years.
–